Fluoptics

Fluoptics is a French medical technology company that specializes in the development of innovative fluorescence imaging systems for real-time surgical guidance. Founded in 2009 as a spin-off from CEA-Leti, the company's core technology, the FLUOBEAM® platform, enables surgeons to visualize physiological phenomena and anatomical structures that are invisible to the naked eye. Its primary applications include the identification and preservation of parathyroid glands during thyroid surgery and the assessment of tissue perfusion in plastic and reconstructive procedures. The company's solutions are designed to minimize surgical complications, reduce operating times, and improve overall patient outcomes. In July 2022, Fluoptics was acquired by Getinge, a global leader in medical technology, to expand its portfolio in the surgical imaging market. Today, Fluoptics continues to operate as a key brand within Getinge's surgical workflows division, serving healthcare providers worldwide.